Hadassah

Hadassah’s Melanoma Maven Featured in Hadassah Magazine

Wednesday, May 10 2017

Metastatic melanoma is typically fatal, but Hadassah Hospital’s Prof. Michal Lotem, a world-renowned, cutting-edge physician/scientist, is trailblazing new treatments that are being watched around the globe.

Prof. Lotem, head of Hadassah’s Melanoma and Cancer Immunotherapy Center, explains: “We developed a way of genetically engineering the few thousand immune system cells from a metastasized tumor into trillions.” And she is not stopping there. She is working to transform immune cells into even more powerful cancer killers so more patients can be saved from this deadly disease.

Yom HaZikaron, Israel’s Remembrance Day, commemorated on May 1, marked Stewart Greenberg’s five-year anniversary to the day of first meeting Prof. Lotem. Diagnosed with stage four melanoma, he had been told by prestigious medical institutions in the United States that there was nothing more they could do for him, but Prof. Lotem was much more optimistic. She saved his life with a personalized melanoma vaccine! “Michal is our angel,” he says.  “She is very modest, but the truth is that she is at the forefront of worldwide melanoma research.”

Read more about how Prof. Lotem is creating a new way to treat skin cancer in this feature story in Hadassah Magazine, "Using the Immune System to Defeat Melanoma."

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Feb 14 2018

Student with MS Running the Jerusalem Marathon to Support Hadassah’s MS Program

Thanks to his physicians at the Hadassah Medical Center, Dov Guggenheim, who was diagnosed with Multiple Sclerosis (MS) in 2015, has gone from “depressed to optimistic, paralyzed to athletic, and, most important, hopeless to hopeful.”

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Texas Tropical Disease Expert Meets with Hadassah Infectious Disease Specialists

Dr. Peter Jay Hotez, renowned professor in the Departments of Pediatrics and Molecular Virology and Microbiology at Houston (Texas) Baylor College of Medicine and Dean of its National School of Tropical Medicine, met with two Hadassah Medical Organization infectious disease specialists to discuss regional cooperation in fighting tropical diseases, such as the now-infamous Zika virus and leishmaniosis, which is contracted from sand flies.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Large Hadassah Study Identifies Predictor of Greater Risk of End-Stage Renal Disease

The findings of a nationwide study of over a million and a half Israeli adolescents, conducted by researchers at the Hadassah-Hebrew University Braun School of Public Health and Community Medicine, suggest that kidney disease in childhood is associated with a significantly increased risk of end-stage renal disease (ESRD) in adulthood, even if kidney function seems normal in adolescence.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Israeli Start-up’s Algorithm Predicts Which Diabetic Patients Will Suffer Kidney Dysfunction Within One Year

The Israeli start-up Medial EarlySign has created a machine-learning-based model that has proven to identify diabetic patients who are at the highest risk for experiencing renal dysfunction within one year.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More